Lagosa milk 150 mg 1 Capsule – Liver Health with Silymarin Extract | Milk Thistle Supplement (Price Per Capsule)
Traditionally used in herbal medicine, milk thistle (Silybum marianum) supports natural detoxification, cell regeneration, and overall liver wellness when taken as part of a balanced lifestyle.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Lagosa Milk 150 mg is a liver health supplement formulated with high-quality milk thistle extract standardized to 150 mg of silymarin, the key bioactive compound known for its liver-supporting and antioxidant properties. Traditionally used in herbal medicine, milk thistle (Silybum marianum) supports natural detoxification, cell regeneration, and overall liver wellness when taken as part of a balanced lifestyle.
Key Benefits:
-
Liver Function Support: Silymarin is widely recognized for its potential to help protect liver cells from oxidative stress and promote natural liver regeneration.
-
Antioxidant Action: Acts as a plant-derived antioxidant that may help neutralize free radicals and support overall metabolic balance.
-
Daily Wellness Supplement: Designed for regular nutritional support as part of a healthy diet.
-
Herbal Formula: Derived from the fruits of milk thistle with a standardized extract ensuring consistent silymarin content.
Usage & Administration:
-
Take 1 capsule daily with water, preferably with food.
-
Do not exceed the recommended dose unless advised by a healthcare professional.
Typical Ingredients:
-
Milk Thistle Dry Extract: Standardized to provide 150 mg of silymarin per serving
-
Additional excipients may include natural binders and capsule materials.
Safety & Precautions:
-
Consult a healthcare provider before use, especially if you are pregnant, breastfeeding, on medication, or have liver disease.
-
Not intended to diagnose, treat, cure, or prevent any disease.
-
Keep out of reach of children.
Storage:
Store in a cool, dry place, away from direct sunlight.











Reviews
There are no reviews yet.